GLPwatch
Papers (12034)
Page 192 of 201, ranked by citation count.
- Community Pharmacists' Knowledge and Counseling Competence on GLP-1 Receptor Agonists in Obesity and Type 2 Diabetes Care in Türkiye: A Cross-Sectional Study.
- Tirzepatide data: safety first is safety always!
- Liraglutide versus colesevelam for treating bile acid diarrhoea - Authors' reply.
- Effect of baseline characteristics on the efficacy of dulaglutide added to basal insulin in Chinese patients with type 2 diabetes: A subgroup analysis of AWARD-CHN3.
- Variables associated with insulin production in persons with type 2 diabetes treated with multiple daily insulin injections.
- Cost-effectiveness of iGlarLixi vs. IDegAsp in individuals with type 2 diabetes: a BRAVO model-based evaluation.
- Trends in publicly subsidized and private access to GLP-1 medicines indicated for type 2 diabetes in Australia, 2020-2025.
- Sintilimab-related fulminant autoimmune diabetes mellitus manifesting as diabetic ketoacidosis and rare insulin resistance: A case report and literature review.
- Efficacy of exenatide, ozone, and methyl prednisolone for the recovery of infraorbital nerve paresthesia after injury in rats.
- Early changes in body composition with tirzepatide in adults with obesity: a real-world BIA study.
- Comparative Effectiveness of Liraglutide versus Dulaglutide in Heart Failure With Preserved Ejection Fraction: A Multicenter Propensity Score-Matched Real-World Study.
- Letter by Ma et al Regarding Article, "Neuroprotective Effects of the Glucagon-Like Peptide-1 Analog Exenatide After Out-of-Hospital Cardiac Arrest: A Randomized Controlled Trial".
- The safety and efficacy of semaglutide in people with schizophrenia spectrum disorders: systematic review and meta-analysis of randomised controlled trials.
- Modulation of metabolic syndrome components by oral semaglutide in hypothyroid-T2DM patients: a retrospective analysis.
- Assessment of Thermal and Photolytic Stress Effects on the Stability of Primary Structure of Synthetic Liraglutide Using LC-HRMS/MS.
- Use of second-generation incretin analogs (GLP-1 and GIP receptor agonists) in type 1 diabetes and latent autoimmune diabetes in adults: A systematic review.
- Comparative Efficacy of Tirzepatide vs Semaglutide on Liver and Cardiovascular Related Outcomes in Patients with MASLD/MASH, Obesity, and Type 2 Diabetes Mellitus: A Real-World Cohort Study.
- Orforglipron: First Approval.
- The need to address the risk of osteosarcopenia induced by tirzepatide therapy.
- Update: Pediatric Diabetes.
- Cardiorenal Safety Markers With Injectable Glucagon-Like Peptide-1 (GLP-1) Agonists in Type 2 Diabetes: A Network Meta-Analysis.
- Incretin-Based Therapies and Heart Failure Outcomes: Benefit Beyond Weight Loss?
- Cardiovascular Outcomes with Tirzepatide in Type 2 Diabetes.
- Euthyroid Sick Syndrome Precipitated By Rapid Weight Loss Following Semaglutide Initiation: A Case Report.
- Diabetic Status, Advanced Age, and Hispanic Ethnicity Predict Poorer Weight Loss in Patients With Obesity Receiving Semaglutide.
- Longitudinal 18F-Fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET) Findings in Korsakoff Syndrome After Rapid Weight Loss During Tirzepatide Therapy: A Case Report.
- Influence without medical expertise: a social network analysis of Mounjaro discussions on twitter (X).
- SURPASS-CVOT and the Emerging Biology of Cardiometabolic Benefit.
- Digital multicriteria evaluation of negotiated medicines using Chinese mini-HTA: application of structured methodologies in assessing once-weekly GLP-1 RAs for improved clinical decision-making.
- The effect of exenatide on fasting bile acids in newly diagnosed type 2 diabetes mellitus patients, a pilot study.
- The role of dulaglutide in the treatment of alcohol use disorder: a case report.
- Semaglutide vs Tirzepatide Dosages for Weight Loss-Reply.
- Effects of Incretin-Based Therapies on Testosterone Levels and Incretin Response in Men with Hypogonadism: A Systematic Literature Review Following PRISMA 2020 Guidelines.
- Experience with dulaglutide in a diabetic and obese patient on incremental peritoneal dialysis.
- Response to "Experience with dulaglutide in an obese diabetic patient on incremental peritoneal dialysis". Response to related letter.
- Severe Euglycemic Ketoacidosis Secondary to Tirzepatide Use for Weight Loss.
- Comparative Effects of Liraglutide-R-Alpha Lipoic Acid Combination and Donepezil on Diazepam-Induced Amnesia in Rats.
- From Glycemic Control to Weight-Centered Therapy: A Paradigm Shift in Type 2 Diabetes and Its Public Health Promise.
- Comparison table: Some FDA-approved drugs for weight management.
- Real-world use of submaximal doses of long-acting GLP-1 receptor agonist semaglutide in patients with obesity: a prospective observational study.
- Tirzepatide and semaglutide: different twins?
- Charge-based supramolecular peptide nanocomplexes for oral delivery via transporter-driven endocytosis.
- Neuroprotective Effects of Semaglutide in Cyclophosphamide-Induced Neuropathy: Restoring SIRT1/AMPK, PI3K/AKT/mTOR, and Antioxidant Pathways.
- Calories to satiation-A new predictor of anti-obesity therapy outcome?
- Cardiovascular Risk Reduction With Tirzepatide, a Dual GIP/GLP-1 Agonist, in Patients With Type 2 Diabetes Mellitus.
- [A meta-analysis of efficacy and safety of anti-obesity medications in the treatment of childhood obesity].
- Comparative effectiveness of continuous positive airway pressure and glucagon-like peptide-1 receptor agonists in obstructive sleep apnea: A network meta-analysis of randomised trials.
- Tirzepatide for Weight Reduction in Chinese Adults With Obesity.
- [Sequential treatment with insulin glargine and metformin, and exenatide in a patient with newly diagnosed type-2 diabetes].
- Care of dental patients on glucagon-like peptide-1 receptor agonists or tirzepatide requiring sedation.
- Incretin-Based Therapies in Obesity-Related Obstructive Sleep Apnea: A Narrative Review of Evidence Tiers and Mechanistic Plausibility.
- GLP1 receptor agonists in heart failure with preserved ejection fraction (HFpEF) - beyond weight loss: a condensed scientific review.
- Pharmacological progress in obesity: tirzepatide's rising advantage over semaglutide.
- Selective amylin receptor agonism: promise beyond incretins.
- Bariatric Surgery in the Era of GLP1RA: A Narrative Review.
- A Case of Severe Hypercalcemia in a Patient Taking Tirzepatide: Potential Risk Factors.
- Interruption of Early Cardiovascular Risk Pathways With GLP-1-Based Therapy for Obesity.
- Glycemic Control and the Weight Benefit of a Daily 7 mg Dose of Oral Semaglutide Versus an Alternate-Day 14 mg Dose of Oral Semaglutide From an Ambulatory Glucose Monitoring Data: A Retrospective Cohort Study From Eastern India.
- Drugs for chronic heart failure.
- Endotypic trait responses to 12-month tirzepatide treatment for an obese patient with obstructive sleep apnea: a case report.